Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02975934
Title	A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)
Acronym	TRITON3
Recruitment	Active, not recruiting
Gender	male
Phase	Phase III
Variant Requirements	Yes
Sponsors	pharmaand GmbH
Indications	prostate adenocarcinoma prostate carcinoma
Therapies	Rucaparib Docetaxel Enzalutamide Abiraterone
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| ISR \| IRL \| GBR \| FRA \| ESP \| DNK \| DEU \| CAN \| BEL \| AUS